Related Experiment Videos
Abstract:
Fifty patients with anaerobic sepsis were treated with intravenous and oral metronidazole. In 26 cases this was combined with other antimicrobial agents. Highly satisfactory clinical results were obtained in most patients, though in many surgical drainage was also essential. No side effects or thrombophlebitis were seen. Mixed growths of anaerobic and aerobic bacteria were isolated from all except five patients, who produced only anaerobes. Metronidazole is the only available antimicrobial agent providing selective activity against anaerobic organisms. It is effective and safe and is usually the drug of choice for treating severe anaerobic sepsis.
Insights
Metronidazole effectively treats anaerobic sepsis, showing high clinical success rates with minimal side effects. Surgical drainage was also crucial for recovery in many patients.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Anaerobic sepsis poses a significant clinical challenge.
- Effective antimicrobial therapy is crucial for managing anaerobic infections.
Purpose of the Study:
- To evaluate the efficacy and safety of metronidazole in treating anaerobic sepsis.
- To assess the role of metronidazole, alone or in combination therapy.
Main Methods:
- A study involving fifty patients diagnosed with anaerobic sepsis.
- Treatment administered included intravenous and oral metronidazole.
- Combination therapy with other antimicrobial agents was used in 26 cases.
Main Results:
- Highly satisfactory clinical outcomes were achieved in most patients.
- Surgical drainage was essential for recovery in a significant number of cases.
- No adverse side effects or thrombophlebitis were observed with metronidazole treatment.
Conclusions:
- Metronidazole is a safe and effective antimicrobial agent for severe anaerobic sepsis.
- It demonstrates selective activity against anaerobic organisms.
- Metronidazole is often the preferred treatment choice for anaerobic infections.